Since diabetes is characterized by the inability of pancreatic β-cells to meet the insulin demand, due to either a nearly complete loss (T1D) or a deficit (T2D and GD) in functional β-cells, this intrinsic plasticity of adult islets opens the possibility of the development of novel regenerative therapies for the cure of this currently chronic disease. The gene discussed is INS; the disease is type 1 diabetes mellitus.